SCHEMBL5773361

SCHEMBL5773361

O=[N+]([O-])c1cccnc1NC1CCCCC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.55
KMT2A Q03164 6/20 0.55
CDK2 P24941 1/20 0.54
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
GAA P10253 3/20 0.47
KDM4E B2RXH2 2/20 0.47
MAPT P10636 3/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
GSK3A P49840 1/20 0.45
GSK3B P49841 1/20 0.45
BLM P54132 1/20 0.45
CDK5 Q00535 1/20 0.45
ATM Q13315 1/20 0.45
CDK5R1 Q15078 1/20 0.45
LMNA P02545 1/20 0.45
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15953915 0.98 MEN1 (0.52) MEN1KMT2ACDK2CYP1A2CYP2C9
SCHEMBL929085 0.92 MAPT (0.50) MEN1KMT2ACDK2CYP1A2CYP2C9
SCHEMBL12124647 0.86 MAPT (0.45) MEN1KMT2ACDK2CYP1A2CYP2C9
SCHEMBL27547587 0.86 MAPT (0.47) MEN1KMT2ACDK2CYP1A2CYP2C9
SCHEMBL15223292 0.86 MAPT (0.47) MEN1KMT2ACDK2CYP1A2CYP2C9
Hydrochloric Acid SCHEMBL15204558 0.85 MAPT (0.44) MEN1KMT2ACYP1A2CYP2C9CYP2C19
Hydrochloric Acid SCHEMBL4714497 0.85 MAPT (0.46) MEN1KMT2ACDK2CYP1A2CYP2C9
Hydrochloric Acid SCHEMBL4714494 0.85 MAPT (0.46) MEN1KMT2ACDK2CYP1A2CYP2C9
SCHEMBL16444047 0.82 ALDH1A1 (0.50) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL16444049 0.82 ALDH1A1 (0.50) MEN1KMT2AMAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7098220-B2 Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same LES LABORATOIRES SERVIER (FR) 2006-08-29 US disclosed
EP-1558612-B1 IMIDAZOPYRIDINE DERIVATIVES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME SERVIER LAB (FR) 2006-08-23 EP disclosed
US-20060069117-A1 Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same LES LABORATOIRES SERVIER (FR) 2006-03-30 US disclosed
EP-1558612-A1 IMIDAZOPYRIDINE DERIVATIVES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME LES LABORATOIRES SERVIER (FR) 2005-08-03 EP disclosed
WO-2004043957-A1 IMIDAZOPYRIDINE DERIVATIVES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME LES LABORATOIRES SERVIER (FR) 2004-05-27 WO disclosed
US-4144341-A ANTIPYRETICS, ANALGESICS AND ANTIINFLAMMATORY AGENTS MERCK & CO., INC. (US) 1979-03-13 US disclosed
US-4000286-A ANALGESICS, ANTIINFLAMMATORY AND ANTIPYRETIC AGENTS MERCK & CO., INC. (US) 1976-12-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060069117-A1 Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same PRKAA1, PRKAB1, PRKAB2 MEN1 3065/4885KMT2A 1946/4885CDK2 1694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.